SRTS
Sensus Healthcare Inc
$
4.020
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
4.080
Open
3.880
VWAP
3.94
Vol
57.33K
Mkt Cap
66.03M
Low
3.840
Amount
225.75K
EV/EBITDA(TTM)
--
Total Shares
16.39M
EV
41.58M
EV/OCF(TTM)
21.79
P/S(TTM)
1.85
Sensus Healthcare, Inc. is a medical device company that is engaged in the development and delivery of non-invasive treatments for skin cancer and keloids. The Company, leveraging its superficial radiotherapy (SRT and IG-SRT) technology, provides healthcare providers with a patient-centric treatment platform. Its products and services include SRT-100, SRT-100 Vision, SRT-100+, Sentinel service program and others. The SRT-100 is a photon x-ray low energy SRT system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides customers with additional options compared to the SRT-100 base model. These additional options allow for dedicated treatment planning and full treatment progression documentation in a patient’s record. The SRT-100+ offers all the same features as the SRT-100, with the addition of remote diagnostics and other features.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q2
FY2026Q1
FY2025Q4
10.62M
+45.14%
-0.010
-83.33%
9.50M
+13.83%
-0.050
-68.75%
8.67M
-33.67%
-0.055
-161.11%
Estimates Revision
The market is revising No Change the revenue expectations for Sensus Healthcare, Inc. (SRTS) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 23.69%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Up
+23.69%
In Past 3 Month
2 Analyst Rating
Wall Street analysts forecast SRTS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SRTS is 7.00 USD with a low forecast of 6.00 USD and a high forecast of 8.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 4.020
Low
6.00
Averages
7.00
High
8.00
Current: 4.020
Low
6.00
Averages
7.00
High
8.00
H.C. Wainwright
Buy
downgrade
$12 -> $8
2025-08-12
Reason
H.C. Wainwright
Price Target
$12 -> $8
2025-08-12
downgrade
Buy
Reason
H.C. Wainwright lowered the firm's price target on Sensus Healthcare to $8 from $12 and keeps a Buy rating on the shares. The firm cites the company's Q2 sales miss for the target cut.
Lake Street
Buy
downgrade
$13 -> $6
2025-08-08
Reason
Lake Street
Price Target
$13 -> $6
2025-08-08
downgrade
Buy
Reason
Lake Street lowered the firm's price target on Sensus Healthcare to $6 from $13 and keeps a Buy rating on the shares. Q2 results fell below expectations and the firm's conclusion from its survey work that suggested upside to the quarter "was flat-out wrong," the analyst tells investors. However, the firm still believes "all roads ultimately lead to greater certainty and should benefit Sensus," the analyst added.
Maxim
Maxim
Buy
downgrade
$14 -> $10
2025-05-19
Reason
Maxim
Maxim
Price Target
$14 -> $10
2025-05-19
downgrade
Buy
Reason
Maxim lowered the firm's price target on Sensus Healthcare to $10 from $14 and keeps a Buy rating on the shares. The firm is updating its estimates to reflect the company's Q1 results and its expectations as well as citing its shift from a pure capital sales model to include its Fair Deal Agreement model, the analyst tells investors in a research note.
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$12
2025-04-04
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$12
2025-04-04
Reiterates
Strong Buy
Reason
Lake Street
Ben Haynor
Strong Buy
Maintains
$18 → $13
2025-03-11
Reason
Lake Street
Ben Haynor
Price Target
$18 → $13
2025-03-11
Maintains
Strong Buy
Reason
Conference call with management will be held on March 4 at 3:30 pm hosted by Lake Street.
HC Wainwright & Co.
Yi Chen
Strong Buy
Maintains
$11 → $12
2025-02-10
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$11 → $12
2025-02-10
Maintains
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Sensus Healthcare Inc (SRTS.O) is -33.50, compared to its 5-year average forward P/E of 10.04. For a more detailed relative valuation and DCF analysis to assess Sensus Healthcare Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
10.04
Current PE
-33.50
Overvalued PE
59.73
Undervalued PE
-39.65
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-73.19
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
314.73
Undervalued EV/EBITDA
-461.11
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
2.60
Current PS
0.00
Overvalued PS
3.63
Undervalued PS
1.57
Financials
Annual
Quarterly
FY2025Q3
YoY :
-22.12%
6.88M
Total Revenue
FY2025Q3
YoY :
-271.84%
-2.57M
Operating Profit
FY2025Q3
YoY :
-177.61%
-943.00K
Net Income after Tax
FY2025Q3
YoY :
-185.71%
-0.06
EPS - Diluted
FY2025Q3
YoY :
-36.64%
2.29M
Free Cash Flow
FY2025Q3
YoY :
-33.52%
39.41
Gross Profit Margin - %
FY2025Q3
YoY :
-199.64%
-13.70
Net Margin - %
Trading Trends
Insider
Insiders areBuying! The selling amount has increased 4278.93% over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
5
147.6K
USD
Months
3-6
1
3.4K
USD
Months
6-9
0
0.0
USD
Months
0-12
2
8.9K
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders areBuying! The selling amount has increased 4278.93% over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
5
147.6K
USD
Months
3-6
1
3.4K
USD
Months
6-9
0
0.0
USD
Months
0-12
2
8.9K
USD
Months
SRTS News & Events
Events Timeline
2025-11-14 (ET)
2025-11-14
08:02:32
Sensus Healthcare names Michael Sardano as chief commercial officer
2025-11-06 (ET)
2025-11-06
16:46:17
Sensus Healthcare announces Q3 earnings per share of 6 cents, below consensus estimate of 11 cents.
2025-11-04 (ET)
2025-11-04
09:07:43
Sensus Healthcare Reveals CMS Treatment Codes for Superficial Radiotherapy
Sign Up For More Events
Sign Up For More Events
News
9.5
11-07NASDAQ.COMSensus Healthcare, Inc. (SRTS) Announces Q3 Loss While Exceeding Revenue Projections
5.0
11-06NewsfilterSensus Healthcare Recognized as One of TIME's Growth Leaders in America for 2026
5.0
10-31NewsfilterSensus Healthcare Reports the Death of Director Bill McCall
Sign Up For More News
People Also Watch
TELA
TELA Bio Inc
1.170
USD
+10.38%
ACHV
Achieve Life Sciences Inc
3.960
USD
+2.06%
CLLS
Cellectis SA
4.690
USD
-1.88%
DLTH
Duluth Holdings Inc
3.080
USD
+2.33%
NVCT
Nuvectis Pharma Inc
6.080
USD
+3.40%
SCLX
Scilex Holding Co
22.510
USD
+18.79%
PHUN
Phunware Inc
1.910
USD
+1.06%
SHMD
SCHMID Group NV
4.150
USD
+7.24%
ATLX
Atlas Lithium Corp
4.870
USD
-1.42%
LGCY
Legacy Education Inc
10.080
USD
+5.00%
FAQ
What is Sensus Healthcare Inc (SRTS) stock price today?
The current price of SRTS is 4.02 USD — it has increased 2.29 % in the last trading day.
What is Sensus Healthcare Inc (SRTS)'s business?
What is the price predicton of SRTS Stock?
What is Sensus Healthcare Inc (SRTS)'s revenue for the last quarter?
What is Sensus Healthcare Inc (SRTS)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Sensus Healthcare Inc (SRTS)'s fundamentals?
How many employees does Sensus Healthcare Inc (SRTS). have?